Red Yeast Rice with CoQ10
Goals
$68.00 $1.13 per serving
Product analysis
Red Yeast Rice with CoQ10 offers CoQ10 for people seeking support related to cellular energy use. Noticeable fatigue or heart-health benefits remain uncertain outside selected groups.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality36
The CoQ10 is identified as ubiquinone, while the red yeast rice preparation is unspecified. Those details do not establish a quality advantage for the combination.
Ingredient Transparency81
Both ingredient amounts and the CoQ10 form are disclosed. The red yeast rice form is unspecified, limiting precise preparation comparisons.
Value For Money24
The serving is expensive when considered for its CoQ10 contribution. Value for the red yeast rice remains uncertain, so its addition does not establish a better buy.
Customer Satisfaction73
Customer ratings are generally positive, with hundreds of opinions available. Ratings describe satisfaction without proving health benefits or safety.
Product Focus74
CoQ10 supplies the clearest link to normal cellular energy use and limited heart-related findings. The wider aims do not establish a lasting metabolism boost, longer lifespan or added benefit from the combination.
- Format
Capsule - Container
- 120 Capsule(s)
- Per serving
- $1.13
- Customer rating
- 4.8 · 101 ratings
Goals
Impact
Highest effect
Coenzyme Q-10 · 200 mg
CoQ10 has limited human findings for blood pressure, lipids and the function of blood-vessel linings, mainly in adults with abnormal lipid levels. This product provides 200 mg of declared CoQ10 per serving. Its ubiquinone form is recognized without establishing superiority over other forms. These marker findings do not establish prevention of heart attacks or strokes.
How this product is rated for Cardiovascular Support
Ingredient fit79
CoQ10 supplies the recognized cardiovascular connection; an additional active reduces the formula's focus within the supplied assessment.
Goal fit
CoQ10 supplies the recognized cardiovascular connection; an additional active reduces the formula's focus within the supplied assessment.
Dose adequacy
The declared CoQ10 serving receives full amount recognition, without implying greater benefit from a larger amount.
Pathways60
The strongest route concerns the function of blood-vessel linings.
Depth
The strongest route concerns the function of blood-vessel linings.
Breadth
Only the vessel-lining route reaches substantial coverage; lipid and other routes are not independently covered.
Evidence88
CoQ10 has limited marker findings in selected populations, rather than established cardiovascular-event prevention.
Evidence strength
CoQ10 has limited marker findings in selected populations, rather than established cardiovascular-event prevention.
Studied preparation
The declared CoQ10 preparation is recognized; no superior delivery-form effect is inferred.
Formulation logic100
No required partner is missing, and none of the checked conflicts was triggered.
Partner coverage
The credited ingredients can contribute without a missing required partner.
Conflicts
No checked stimulant or high-sodium conflict was triggered.
Effective doses
CoQ10 meets the amount threshold used for a meaningful contribution.
Impact
Moderate effect
Coenzyme Q-10 · 200 mg
CoQ10 at 200 mg provides a connection to normal cellular energy production and antioxidant defences. The human aging evidence supplied is narrow and preparation specific, concerning selected skin outcomes. It does not establish longer lifespan or general rejuvenation.
How this product is rated for Longevity
Ingredient fit79
The relevant ingredients provide a reasonable connection within a broader formula. The counted amounts align well with the saved dose comparison ranges.
Goal fit
The relevant ingredients provide a reasonable connection within a broader formula.
Dose adequacy
The counted amounts align well with the saved dose comparison ranges.
Pathways40
The strongest assessed connection is mitochondrial energy production, with moderate coverage. One mechanism reaches the saved coverage threshold; the contribution remains concentrated.
Depth
The strongest assessed connection is mitochondrial energy production, with moderate coverage.
Breadth
One mechanism reaches the saved coverage threshold; the contribution remains concentrated.
Evidence30
Coenzyme Q-10 provides the strongest relevant evidence among ingredients counted at meaningful amounts. That comparison does not establish lifespan extension. The assessed material is not matched to the specific preparation used in the reviewed aging-related trial.
Evidence strength
Coenzyme Q-10 provides the strongest relevant evidence among ingredients counted at meaningful amounts. That comparison does not establish lifespan extension.
Studied preparation
The assessed material is not matched to the specific preparation used in the reviewed aging-related trial.
Formulation logic100
The counted ingredients can contribute independently or have their required partner. No ingredient conflict was identified in the saved assessment. 1 of 1 counted ingredients reach the saved meaningful-amount threshold.
Partner coverage
The counted ingredients can contribute independently or have their required partner.
Conflicts
No ingredient conflict was identified in the saved assessment.
Effective doses
1 of 1 counted ingredients reach the saved meaningful-amount threshold.
Impact
Highest effect
Coenzyme Q-10 · 200 mg
CoQ10 has limited support for blood-vessel function, blood-pressure and lipid measures from small studies in selected populations. The declared preparation and amount receive recognition, but those findings do not establish prevention of major cardiovascular events. No delivery advantage or extra benefit from a companion ingredient is established by the supplied facts.
How this product is rated for Heart Health
Ingredient fit79
The relevant ingredients provide a partial heart-health connection. Their declared amounts receive full recognition.
Goal fit
The recognized ingredients provide a heart-health connection within a broader formula, reducing its overall focus on this goal.
Dose adequacy
The declared active amounts receive full recognition in the saved exposure comparison, without establishing clinical benefit.
Pathways60
The strongest saved connection is blood-vessel function. The contribution is concentrated in this route.
Depth
The strongest saved route is blood-vessel function, with coverage limited by the recognized preparation and amount.
Breadth
One route reaches the saved coverage threshold, so the contribution remains focused rather than broad.
Evidence98
Coenzyme Q-10 supplies the strongest recognized evidence, which concerns selected physiological measures rather than established general event prevention.
Evidence strength
Coenzyme Q-10 supplies the strongest recognized evidence, which concerns selected physiological measures rather than established general event prevention.
Studied preparation
The saved result recognizes studied preparations among the ingredients meeting its amount criteria; matching preparation does not guarantee the same clinical outcome.
Formulation logic100
No configured conflicts or missing required partners were found. The ingredients included in the amount finding clear its minimum threshold.
Partner coverage
The recognized ingredients work independently or have the required partners; no added combined benefit is established.
Conflicts
No configured ingredient conflicts were found in the supplied formula.
Effective doses
All ingredients included in this finding clear the saved minimum amount threshold, without proving clinical effectiveness.
Impact
High effect
Coenzyme Q-10 · 200 mg
Coenzyme Q10 participates in mitochondrial energy production and has limited, preparation-specific evidence for fatigue relief. This product identifies ubiquinone and its amount is recognized in the saved findings. Results from clinical disease groups do not establish the same benefit for routine use by healthy adults, and its cellular role alone does not prove a noticeable energy boost.
How this product is rated for Energy
Ingredient fit79
Ubiquinone is the relevant fatigue ingredient, and its amount is recognized.
Goal fit
Relevant ingredients sit within a broader formula containing ingredients without an assessed energy contribution.
Dose adequacy
The relevant amounts receive full recognition in the saved findings; this does not establish greater benefit or a treatment dose.
Pathways53
The direct finding is confined to mitochondrial energy production through ubiquinone.
Depth
Ubiquinone is the main contributor to the mitochondrial energy-production finding.
Breadth
Only mitochondrial energy production is represented among the evaluated direct energy routes.
Evidence84
Ubiquinone drives this finding, with limited fatigue evidence that cannot be generalized from clinical groups to routine healthy use.
Evidence strength
Ubiquinone drives this finding, with limited fatigue evidence that cannot be generalized from clinical groups to routine healthy use.
Studied preparation
Ubiquinone is identified and accepted against the supplied preparation requirement.
Formulation logic100
No required partner is missing and no specified conflict was identified. Included ingredients satisfy the saved minimum amount requirement.
Partner coverage
The relevant ingredients do not require a missing partner in the saved findings.
Conflicts
No specified ingredient conflict was identified in the supplied facts.
Effective doses
All included ingredients pass the saved minimum amount requirement; this is not a proven fatigue-treatment threshold.
Impact
High effect
Coenzyme Q-10 · 200 mg
CoQ10 participates in cellular energy production, but this normal role does not establish that supplementation increases whole-body energy use. The supplied findings do not show a lasting metabolism boost or an advantage from a particular CoQ10 form.
How this product is rated for Metabolism Support
Ingredient fit79
CoQ10 accounts for the counted contribution, with its declared serving amount determining the comparison.
Goal fit
CoQ10 supplies the counted goal-related contribution.
Dose adequacy
The counted amounts meet the full saved references; this does not establish a clinical dose for raising metabolic rate.
Pathways54
The main recorded contribution concerns mitochondrial energy and fat oxidation; this does not by itself demonstrate increased whole-body energy use.
Depth
The main recorded contribution concerns mitochondrial energy and fat oxidation; this does not by itself demonstrate increased whole-body energy use.
Breadth
Coverage is limited to one evaluated mechanism, rather than a broad set of routes to increased energy expenditure.
Evidence75
The saved evidence comparison accepts nutrient or cellular roles, while the supplied scientific context limits claims of increased energy expenditure.
Evidence strength
Coenzyme Q-10 leads the saved evidence comparison, but its physiological role or metabolic-marker findings do not establish a routine increase in energy expenditure.
Studied preparation
The counted preparations meet the saved preparation comparison; this does not prove a particular form raises metabolic rate more effectively.
Formulation logic100
There are no unmet partner requirements or configured conflicts. The amount findings describe the counted ingredients, without establishing combined metabolic benefits.
Partner coverage
No counted ingredient has an unmet partner requirement in the supplied findings.
Conflicts
No configured ingredient conflict was triggered.
Effective doses
All counted ingredients meet the saved minimum amount criterion, which is not proof of increased metabolic rate.
Impact
High effect
Coenzyme Q-10 · 200 mg
Coenzyme Q10 in its ubiquinone form relates to oxidative and mitochondrial stress. A small trial in statin-treated people with coronary artery disease found a change in one inflammatory marker, while others were unchanged; this does not establish routine clinical benefit. The selected serving contains less ubiquinone than the reviewed daily regimen.
How this product is rated for Inflammation
Ingredient fit66
The formula includes ingredients for other purposes, which reduces its focus on inflammation-related support. The ubiquinone serving falls below the reviewed 300 mg/day regimen, limiting the exposure match.
Goal fit
The formula includes ingredients for other purposes, which reduces its focus on inflammation-related support.
Dose adequacy
The ubiquinone serving falls below the reviewed 300 mg/day regimen, limiting the exposure match.
Pathways46
The strongest recorded connection is oxidative and mitochondrial stress, with partial coverage in the saved comparison. Coverage remains concentrated in one route.
Depth
The strongest recorded connection is oxidative and mitochondrial stress, with partial coverage in the saved comparison.
Breadth
One pathway reaches the saved coverage threshold; the formula does not provide broad coverage across the inflammation-related routes.
Evidence93
Ubiquinone supplies the strongest recorded human-evidence contribution. The reviewed finding concerns selected inflammatory markers in statin-treated coronary artery disease.
Evidence strength
Ubiquinone supplies the strongest recorded human-evidence contribution.
Studied preparation
The counted preparations match those recognized in the saved comparison; this does not establish equivalent clinical results.
Formulation logic100
Partner requirements are met and no configured conflict was recorded. The counted ingredients reach the saved amount threshold.
Partner coverage
The counted ingredients can stand alone or have the partners required by the saved comparison; no added benefit from combining them is established.
Conflicts
No configured ingredient conflict was recorded; this finding is limited to the interactions checked.
Effective doses
The counted ingredients meet the saved minimum amount threshold; that threshold is not a proven effective dose.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Red Yeast Rice Concentrate | 1200 mg | |
CoEnzyme Q10 (Ubiquinone) | 200 mg |
Coenzyme Q-10 (Ubiquinone) · 200 mg OverallScore63
Each serving provides 200 mg of CoQ10 as ubiquinone. Ubiquinone is a form the body converts to ubiquinol.
How this ingredient is rated
Active Ingredient Quality & Bioavailability48
Ubiquinone is the stated form; the body converts it to ubiquinol.
Molecular Form: Ubiquinol vs. Ubiquinone
Ubiquinone is the stated form of CoQ10; the body converts it to ubiquinol.
Formulation & Absorption Enhancers
The saved facts do not establish a specified absorption-enhancing technology or black pepper extract.
Dose, Safety & Label Transparency100
The stated CoQ10 amount is 200 mg per serving as ubiquinone.
Clinical Dosage Alignment
The serving contains 200 mg of ubiquinone, a substantial amount in this comparison.
Label Transparency & Fillers
The CoQ10 amount is clear, and the evaluation flags no standard fillers or specified problematic additives.
Value20
A whole-product serving costs about $1.13, which is high in this comparison. The price covers the entire product.
Price Per Effective Serving
A whole-product serving costs about $1.13, which is high in this comparison.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
- Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
- The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
- [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
- Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
- Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
- Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
- Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Antifatigue effects of coenzyme Q10 during physical fatigue.
- Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
- Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
- Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
- Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
- The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
- The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
- Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
- Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
- Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
- Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.